100 related articles for article (PubMed ID: 7269824)
1. [Effect of uremic plasma fractions of different molecular sizes on the filterability of red blood cells].
Eggert W; Scigalla P; Noack C; Devaux S; Wolf S
Z Urol Nephrol; 1981 May; 74(5):391-9. PubMed ID: 7269824
[TBL] [Abstract][Full Text] [Related]
2. [Uremic plasma as cause of metabolic changes in red blood cells].
Eggert W; Schmidt G; Devaux S
Z Urol Nephrol; 1981 Feb; 74(2):141-7. PubMed ID: 7223096
[TBL] [Abstract][Full Text] [Related]
3. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
4. In vitro cytotoxic properties of plasma fractions from uremic patients.
Delaporte C; Gros F; Jonsson C; Bergström J
Artif Organs; 1981; 4 Suppl():68-70. PubMed ID: 7295099
[TBL] [Abstract][Full Text] [Related]
5. [On-line HFR and removal of uremic toxins inducing the loss of phospholipidic asymmetry of the erythrocyte membrane].
Sirolli V; Cappelli P; Amoroso L; Di Liberato L; Muscianese P; Santarelli P; Del Rosso G; Bonomini M
G Ital Nefrol; 2004; 21 Suppl 30():S208-11. PubMed ID: 15750987
[TBL] [Abstract][Full Text] [Related]
6. Removal of uremic toxins and regeneration of hemofiltrate by a selective dual hemofiltration artificial kidney (SEDUFARK) system.
Jørstad S; Smeby LC; Widerøe TE; Berg KJ
Clin Nephrol; 1980 Feb; 13(2):85-92. PubMed ID: 6988123
[TBL] [Abstract][Full Text] [Related]
7. In vitro cytotoxic properties of plasma samples from uremic patients.
Delaporte C; Gros F; Jonsson C; Bergström J
Clin Nephrol; 1982 May; 17(5):247-53. PubMed ID: 7094441
[TBL] [Abstract][Full Text] [Related]
8. Osmotic concentration of polypeptides from hemofiltrate of uremic patients.
Ehrlich K; Holland F; Turnham T; Klein E
Clin Nephrol; 1980 Jul; 14(1):31-5. PubMed ID: 7408253
[TBL] [Abstract][Full Text] [Related]
9. [Effect of dialysis on Na+/K+-ATP-ase activity in uremic children].
Vásárhelyi B; Reusz G; Sallay P; Tulassay T
Orv Hetil; 1996 Oct; 137(40):2193-6. PubMed ID: 8927368
[TBL] [Abstract][Full Text] [Related]
10. [An effect of chromatographic fraction ultrafiltrate of plasma on aggregation of blood platelets in patients with chronic uremia].
Popławski A; Myśliwiec M
Pol Merkur Lekarski; 1996 Oct; 1(4):246-8. PubMed ID: 9156935
[TBL] [Abstract][Full Text] [Related]
11. Phosphate in dialysis patients.
Sugisaki H; Onohara M; Kunitomo T
Trans Am Soc Artif Intern Organs; 1983; 29():38-43. PubMed ID: 6673257
[TBL] [Abstract][Full Text] [Related]
12. Tin-protein binding kinetics in normal and uremic plasma and its effect on dialysis fluxes.
Maher JF; Montero G; Chieffo S
Trans Am Soc Artif Intern Organs; 1976; 22():149-54. PubMed ID: 951835
[TBL] [Abstract][Full Text] [Related]
13. Middle-sized molecule fractions isolated from uremic ultrafiltrate and normal urine inhibit ingestive behavior in the rat.
Anderstam B; Mamoun AH; Södersten P; Bergström J
J Am Soc Nephrol; 1996 Nov; 7(11):2453-60. PubMed ID: 8959639
[TBL] [Abstract][Full Text] [Related]
14. Filtrability investigations with red blood cell (RBC) suspensions: effects of different blood components and pentoxifylline on RBC flow rate.
Seiffge D; Kiesewetter H
Ric Clin Lab; 1981; 11 Suppl 1():117-23. PubMed ID: 7188104
[TBL] [Abstract][Full Text] [Related]
15. Rheological properties of red blood cells (including reticulocytes) in patients with chronic renal disease.
Nowak E; Wyrwicz G; Dabrowski Z; Smoleńiski O; Spodaryk K
Clin Hemorheol Microcirc; 1999; 21(2):87-94. PubMed ID: 10599591
[TBL] [Abstract][Full Text] [Related]
16. Loss of phospholipids asymmetry in red blood cells contributes to anemia in uremic patients.
Kong QY; Wu X; Li J; Peng WX; Ye R; Lindholm B; Wang T
Adv Perit Dial; 2001; 17():58-60. PubMed ID: 11510298
[TBL] [Abstract][Full Text] [Related]
17. Inhibitor of insulin binding to erythrocytes in plasma of uremic patients.
Milutinović S; Breyer D; Janković N; Molnar V; Stefović A; Rocić B
Nephron; 1983; 34(2):99-103. PubMed ID: 6346120
[TBL] [Abstract][Full Text] [Related]
18. Effect of erythropoietin therapy and selenium supplementation on selected antioxidant parameters in blood of uremic patients on long-term hemodialysis.
Adamowicz A; Trafikowska U; Trafikowska A; Zachara B; Manitius J
Med Sci Monit; 2002 Mar; 8(3):CR202-5. PubMed ID: 11887037
[TBL] [Abstract][Full Text] [Related]
19. The role of erythrocytes phosphatidylserine exposure in anemia in peritoneal dialysis patients.
Bi SH; Cheng LT; Wang T
Ren Fail; 2006; 28(7):573-6. PubMed ID: 17050240
[TBL] [Abstract][Full Text] [Related]
20. Comparison of dialysis programmes on different molecular prescriptions: a preliminary study.
Nakagawa S; Suenaga M; Sasaki S; Yoshiyama N; Takeuchi J; Kitaoka T; Koshikawa S; Yamada T
Proc Eur Dial Transplant Assoc; 1977; 14():167-73. PubMed ID: 600953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
